Syros Pharmaceuticals Inc... (SYRS)
NASDAQ: SYRS
· Real-Time Price · USD
0.03
0.00 (19.52%)
At close: Jun 09, 2025, 3:26 PM
Syros Pharmaceuticals Ratios and Metrics
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
PE Ratio | -3.3 | -2.07 | -13.24 | -0.89 | -0.69 | -0.61 | -1.25 | 0.90 | -0.72 | -0.44 | -0.79 | -2.15 | -2.7 | -3.78 | -8.07 |
PEG Ratio | 0.05 | -0.00 | 0.14 | -0.02 | -0.07 | -0.00 | 0.01 | -0.01 | 0.01 | -0.01 | 1.00 | 0.25 | -0.18 | -0.07 | 0.15 |
PS Ratio | n/a | n/a | n/a | 596.20 | 29.39 | 31.04 | 25.17 | -18.22 | 15.59 | 9.79 | 13.73 | 26.29 | 49.38 | 65.96 | 95.11 |
PB Ratio | -7.59 | -30.48 | 13.05 | 13.81 | 3.05 | 1.20 | 0.70 | 0.78 | 0.47 | 1.98 | 1.20 | 2.41 | 2.65 | 2.62 | 3.06 |
P/FCF Ratio | -4.08 | -6.53 | -6.32 | -12.37 | -3.47 | -3.93 | -2 | -3.14 | -1.68 | -2.34 | -2.49 | -8.84 | -9.89 | -12.67 | -20.63 |
P/OCF Ratio | -4.08 | -6.53 | -6.32 | -12.4 | -3.47 | -3.93 | -2.01 | -3.21 | -1.69 | -2.35 | -2.5 | -8.93 | -10 | -12.87 | -20.88 |
OCF/S Ratio | n/a | n/a | n/a | -48.1 | -8.47 | -7.9 | -12.49 | 5.69 | -9.2 | -4.17 | -5.49 | -2.94 | -4.94 | -5.12 | -4.56 |
Debt / Equity Ratio | -5.41 | -9.55 | 4.10 | 3.73 | 1.72 | 0.86 | 0.59 | 0.50 | 0.50 | 2.08 | 1.03 | 0.76 | 0.62 | 0.51 | 0.44 |
Quick Ratio | 2.25 | 3.46 | 3.01 | 3.95 | 4.31 | 5.38 | 7.37 | 6.87 | 6.57 | 2.36 | 4.22 | 4.33 | 5.13 | 6.74 | 8.28 |
Current Ratio | 2.25 | 3.46 | 3.01 | 3.95 | 4.31 | 5.38 | 7.37 | 6.87 | 6.57 | 2.36 | 4.22 | 4.33 | 5.13 | 6.74 | 8.28 |
Asset Turnover | n/a | n/a | n/a | 0.00 | 0.03 | 0.02 | 0.01 | -0.02 | 0.01 | 0.05 | 0.04 | 0.04 | 0.03 | 0.02 | 0.02 |
Interest Coverage | -19.96 | -19.84 | -23.66 | -20.32 | -26.58 | -26.6 | -27.29 | -31.97 | -37.54 | -34.42 | -27.31 | -25.78 | -27.35 | -26.98 | -21.66 |
Return on Equity | 0.58 | 3.67 | -0.25 | -3.86 | -1.11 | -0.5 | -0.14 | 0.22 | -0.16 | -1.13 | -0.38 | -0.28 | -0.25 | -0.17 | -0.09 |
Return on Assets | -0.08 | -0.22 | -0.03 | -0.38 | -0.27 | -0.2 | -0.07 | 0.11 | -0.07 | -0.28 | -0.16 | -0.13 | -0.13 | -0.1 | -0.05 |
Return on Invested Capital | -0.42 | -0.31 | -0.3 | -0.22 | -0.25 | -0.22 | -0.11 | 0.96 | -0.11 | -0.35 | -0.19 | -0.17 | -0.15 | -0.13 | -0.09 |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | n/a | n/a | 0.28 | 0.84 | 0.77 | 0.76 | 1.14 | 0.81 | 0.88 | 0.86 | 1.00 | 1.00 | 1.00 | 1.00 |
Net Profit Margin | n/a | n/a | n/a | -166.8 | -10.67 | -12.8 | -5.05 | -5.04 | -5.41 | -5.61 | -4.32 | -3.05 | -4.57 | -4.36 | -2.95 |
Pretax Profit Margin | n/a | n/a | n/a | -166.8 | -10.67 | -12.8 | -8.05 | 0.87 | -7.78 | -5.49 | -4.6 | -3.05 | -4.57 | -4.36 | -2.95 |
Operating Profit Margin | n/a | n/a | n/a | -69.96 | -9.21 | -12 | -11.24 | 6.58 | -10.14 | -5.38 | -4.88 | -3.26 | -4.72 | -5.06 | -4.34 |
FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | n/a | n/a | n/a | -162.63 | -10.16 | -12.12 | -7.4 | 0.53 | -7.32 | -5.22 | -4.28 | -2.83 | -4.26 | -4.02 | -2.6 |